• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jun 1, 2018
Clinical News

Gilead's Epclusa approved in China for HCV

Read More
BioCentury | May 30, 2018
Company News

Gilead's Epclusa approved in China for HCV

Read More
BioCentury | Dec 2, 2017
Strategy

Opening the gates in China

HCV competition in China shows how regulatory changes have leveled the field
Read More
BioCentury | Sep 29, 2017
Clinical News

China approves HCV drugs from Gilead and AbbVie

Read More
BioCentury | Sep 25, 2017
Company News

Gilead's Sovaldi gets Chinese approval

Read More
BioCentury | May 19, 2017
Strategy

Contracting 2.0

The why, when, how -- and why not -- of value-based deals
Read More
BioCentury | Jan 27, 2017
Clinical News

Glecaprevir/pibrentasvir: Ph III CERTAIN-1 data

Read More
BioCentury | Dec 16, 2016
Company News

Harvoni sales and marketing update

Read More
BioCentury | Dec 15, 2016
Clinical News

Direct-acting antivirals regulatory update

Read More
BioCentury | Dec 13, 2016
Company News

Express Scripts adds Harvoni, expands indication-based pricing

Read More
Items per page:
1 - 10 of 55
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa